Copyright Reports & Markets. All rights reserved.

Global Hyperthermia Cancer Treatment Systems Market Research Report 2021

Request for Sample of this report
Buy now

1 Hyperthermia Cancer Treatment Systems Market Overview

  • 1.1 Product Overview and Scope of Hyperthermia Cancer Treatment Systems
  • 1.2 Hyperthermia Cancer Treatment Systems Segment by Type
    • 1.2.1 Global Hyperthermia Cancer Treatment Systems Sales Growth Rate Comparison by Type (2021-2027)
    • 1.2.2 Local Hyperthermia System
    • 1.2.3 Whole Body Hyperthermia System
  • 1.3 Hyperthermia Cancer Treatment Systems Segment by Application
    • 1.3.1 Global Hyperthermia Cancer Treatment Systems Sales Comparison by Application: (2021-2027)
    • 1.3.2 Breast Cancer
    • 1.3.3 Liver Cancer
    • 1.3.4 Soft Tissue Sarcoma
    • 1.3.5 Head & Neck Tumors
    • 1.3.6 Prostate Cancer
    • 1.3.7 Others
  • 1.4 Global Hyperthermia Cancer Treatment Systems Market Size Estimates and Forecasts
    • 1.4.1 Global Hyperthermia Cancer Treatment Systems Revenue 2016-2027
    • 1.4.2 Global Hyperthermia Cancer Treatment Systems Sales 2016-2027
    • 1.4.3 Hyperthermia Cancer Treatment Systems Market Size by Region: 2016 Versus 2021 Versus 2027

2 Hyperthermia Cancer Treatment Systems Market Competition by Manufacturers

  • 2.1 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Manufacturers (2016-2021)
  • 2.2 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Manufacturers (2016-2021)
  • 2.3 Global Hyperthermia Cancer Treatment Systems Average Price by Manufacturers (2016-2021)
  • 2.4 Manufacturers Hyperthermia Cancer Treatment Systems Manufacturing Sites, Area Served, Product Type
  • 2.5 Hyperthermia Cancer Treatment Systems Market Competitive Situation and Trends
    • 2.5.1 Hyperthermia Cancer Treatment Systems Market Concentration Rate
    • 2.5.2 The Global Top 5 and Top 10 Largest Hyperthermia Cancer Treatment Systems Players Market Share by Revenue
    • 2.5.3 Global Hyperthermia Cancer Treatment Systems Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hyperthermia Cancer Treatment Systems Retrospective Market Scenario by Region

  • 3.1 Global Hyperthermia Cancer Treatment Systems Retrospective Market Scenario in Sales by Region: 2016-2021
  • 3.2 Global Hyperthermia Cancer Treatment Systems Retrospective Market Scenario in Revenue by Region: 2016-2021
  • 3.3 North America Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
    • 3.3.1 North America Hyperthermia Cancer Treatment Systems Sales by Country
    • 3.3.2 North America Hyperthermia Cancer Treatment Systems Revenue by Country
    • 3.3.3 United States
    • 3.3.4 Canada
  • 3.4 Europe Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
    • 3.4.1 Europe Hyperthermia Cancer Treatment Systems Sales by Country
    • 3.4.2 Europe Hyperthermia Cancer Treatment Systems Revenue by Country
    • 3.4.3 Germany
    • 3.4.4 France
    • 3.4.5 U.K.
    • 3.4.6 Italy
    • 3.4.7 Russia
  • 3.5 Asia Pacific Hyperthermia Cancer Treatment Systems Market Facts & Figures by Region
    • 3.5.1 Asia Pacific Hyperthermia Cancer Treatment Systems Sales by Region
    • 3.5.2 Asia Pacific Hyperthermia Cancer Treatment Systems Revenue by Region
    • 3.5.3 China
    • 3.5.4 Japan
    • 3.5.5 South Korea
    • 3.5.6 India
    • 3.5.7 Australia
    • 3.5.8 Taiwan
    • 3.5.9 Indonesia
    • 3.5.10 Thailand
    • 3.5.11 Malaysia
  • 3.6 Latin America Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
    • 3.6.1 Latin America Hyperthermia Cancer Treatment Systems Sales by Country
    • 3.6.2 Latin America Hyperthermia Cancer Treatment Systems Revenue by Country
    • 3.6.3 Mexico
    • 3.6.4 Brazil
    • 3.6.5 Argentina
    • 3.6.6 Colombia
  • 3.7 Middle East and Africa Hyperthermia Cancer Treatment Systems Market Facts & Figures by Country
    • 3.7.1 Middle East and Africa Hyperthermia Cancer Treatment Systems Sales by Country
    • 3.7.2 Middle East and Africa Hyperthermia Cancer Treatment Systems Revenue by Country
    • 3.7.3 Turkey
    • 3.7.4 Saudi Arabia
    • 3.7.5 UAE

4 Global Hyperthermia Cancer Treatment Systems Historic Market Analysis by Type

  • 4.1 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Type (2016-2021)
  • 4.2 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Type (2016-2021)
  • 4.3 Global Hyperthermia Cancer Treatment Systems Price by Type (2016-2021)

5 Global Hyperthermia Cancer Treatment Systems Historic Market Analysis by Application

  • 5.1 Global Hyperthermia Cancer Treatment Systems Sales Market Share by Application (2016-2021)
  • 5.2 Global Hyperthermia Cancer Treatment Systems Revenue Market Share by Application (2016-2021)
  • 5.3 Global Hyperthermia Cancer Treatment Systems Price by Application (2016-2021)

6 Key Companies Profiled

  • 6.1 PYREXAR Medical
    • 6.1.1 PYREXAR Medical Corporation Information
    • 6.1.2 PYREXAR Medical Description and Business Overview
    • 6.1.3 PYREXAR Medical Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.1.4 PYREXAR Medical Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.1.5 PYREXAR Medical Recent Developments/Updates
  • 6.2 Celsius43 GmbH
    • 6.2.1 Celsius43 GmbH Corporation Information
    • 6.2.2 Celsius43 GmbH Description and Business Overview
    • 6.2.3 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.2.4 Celsius43 GmbH Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.2.5 Celsius43 GmbH Recent Developments/Updates
  • 6.3 Hydrosun GmbH
    • 6.3.1 Hydrosun GmbH Corporation Information
    • 6.3.2 Hydrosun GmbH Description and Business Overview
    • 6.3.3 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.3.4 Hydrosun GmbH Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.3.5 Hydrosun GmbH Recent Developments/Updates
  • 6.4 Oncotherm Kft.
    • 6.4.1 Oncotherm Kft. Corporation Information
    • 6.4.2 Oncotherm Kft. Description and Business Overview
    • 6.4.3 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Oncotherm Kft. Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.4.5 Oncotherm Kft. Recent Developments/Updates
  • 6.5 Andromedic S.r.l.
    • 6.5.1 Andromedic S.r.l. Corporation Information
    • 6.5.2 Andromedic S.r.l. Description and Business Overview
    • 6.5.3 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.5.4 Andromedic S.r.l. Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.5.5 Andromedic S.r.l. Recent Developments/Updates
  • 6.6 Yamamoto Vinita Co. Ltd
    • 6.6.1 Yamamoto Vinita Co. Ltd Corporation Information
    • 6.6.2 Yamamoto Vinita Co. Ltd Description and Business Overview
    • 6.6.3 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.6.4 Yamamoto Vinita Co. Ltd Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.6.5 Yamamoto Vinita Co. Ltd Recent Developments/Updates
  • 6.7 Chongqing Haifu Medical Technology Co. Ltd.
    • 6.6.1 Chongqing Haifu Medical Technology Co. Ltd. Corporation Information
    • 6.6.2 Chongqing Haifu Medical Technology Co. Ltd. Description and Business Overview
    • 6.6.3 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.4.4 Chongqing Haifu Medical Technology Co. Ltd. Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.7.5 Chongqing Haifu Medical Technology Co. Ltd. Recent Developments/Updates
  • 6.8 innoMedicus Ltd.
    • 6.8.1 innoMedicus Ltd. Corporation Information
    • 6.8.2 innoMedicus Ltd. Description and Business Overview
    • 6.8.3 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.8.4 innoMedicus Ltd. Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.8.5 innoMedicus Ltd. Recent Developments/Updates
  • 6.9 Gamida-Cell Ltd.
    • 6.9.1 Gamida-Cell Ltd. Corporation Information
    • 6.9.2 Gamida-Cell Ltd. Description and Business Overview
    • 6.9.3 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.9.4 Gamida-Cell Ltd. Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.9.5 Gamida-Cell Ltd. Recent Developments/Updates
  • 6.10 RanD
    • 6.10.1 RanD Corporation Information
    • 6.10.2 RanD Description and Business Overview
    • 6.10.3 RanD Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.10.4 RanD Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.10.5 RanD Recent Developments/Updates
  • 6.11 Gentherm
    • 6.11.1 Gentherm Corporation Information
    • 6.11.2 Gentherm Hyperthermia Cancer Treatment Systems Description and Business Overview
    • 6.11.3 Gentherm Hyperthermia Cancer Treatment Systems Sales, Revenue and Gross Margin (2016-2021)
    • 6.11.4 Gentherm Hyperthermia Cancer Treatment Systems Product Portfolio
    • 6.11.5 Gentherm Recent Developments/Updates

7 Hyperthermia Cancer Treatment Systems Manufacturing Cost Analysis

  • 7.1 Hyperthermia Cancer Treatment Systems Key Raw Materials Analysis
    • 7.1.1 Key Raw Materials
    • 7.1.2 Key Suppliers of Raw Materials
  • 7.2 Proportion of Manufacturing Cost Structure
  • 7.3 Manufacturing Process Analysis of Hyperthermia Cancer Treatment Systems
  • 7.4 Hyperthermia Cancer Treatment Systems Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

  • 8.1 Marketing Channel
  • 8.2 Hyperthermia Cancer Treatment Systems Distributors List
  • 8.3 Hyperthermia Cancer Treatment Systems Customers

9 Hyperthermia Cancer Treatment Systems Market Dynamics

  • 9.1 Hyperthermia Cancer Treatment Systems Industry Trends
  • 9.2 Hyperthermia Cancer Treatment Systems Growth Drivers
  • 9.3 Hyperthermia Cancer Treatment Systems Market Challenges
  • 9.4 Hyperthermia Cancer Treatment Systems Market Restraints

10 Global Market Forecast

  • 10.1 Hyperthermia Cancer Treatment Systems Market Estimates and Projections by Type
    • 10.1.1 Global Forecasted Sales of Hyperthermia Cancer Treatment Systems by Type (2022-2027)
    • 10.1.2 Global Forecasted Revenue of Hyperthermia Cancer Treatment Systems by Type (2022-2027)
  • 10.2 Hyperthermia Cancer Treatment Systems Market Estimates and Projections by Application
    • 10.2.1 Global Forecasted Sales of Hyperthermia Cancer Treatment Systems by Application (2022-2027)
    • 10.2.2 Global Forecasted Revenue of Hyperthermia Cancer Treatment Systems by Application (2022-2027)
  • 10.3 Hyperthermia Cancer Treatment Systems Market Estimates and Projections by Region
    • 10.3.1 Global Forecasted Sales of Hyperthermia Cancer Treatment Systems by Region (2022-2027)
    • 10.3.2 Global Forecasted Revenue of Hyperthermia Cancer Treatment Systems by Region (2022-2027)

11 Research Finding and Conclusion

    12 Methodology and Data Source

    • 12.1 Methodology/Research Approach
      • 12.1.1 Research Programs/Design
      • 12.1.2 Market Size Estimation
      • 12.1.3 Market Breakdown and Data Triangulation
    • 12.2 Data Source
      • 12.2.1 Secondary Sources
      • 12.2.2 Primary Sources
    • 12.3 Author List

    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

    Segment by Type
    Local Hyperthermia System
    Whole Body Hyperthermia System

    Segment by Application
    Breast Cancer
    Liver Cancer
    Soft Tissue Sarcoma
    Head & Neck Tumors
    Prostate Cancer
    Others

    By Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    By Company
    PYREXAR Medical
    Celsius43 GmbH
    Hydrosun GmbH
    Oncotherm Kft.
    Andromedic S.r.l.
    Yamamoto Vinita Co. Ltd
    Chongqing Haifu Medical Technology Co. Ltd.
    innoMedicus Ltd.
    Gamida-Cell Ltd.
    RanD
    Gentherm

    Buy now